Attached files
| file | filename |
|---|---|
| EX-10.1 - LETTER AGREEMENT, DATED MARCH 15, 2021, BETWEEN THE COMPANY AND MR. LEE - TCW Special Purpose Acquisition Corp. | ea137695ex10-1_tcwspecial.htm |
| EX-10.2 - INDEMNITY AGREEMENT, DATED MARCH 15, 2021, BETWEEN THE COMPANY AND MR. LEE - TCW Special Purpose Acquisition Corp. | ea137695ex10-2_tcwspecial.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): March 15, 2021
TCW Special Purpose Acquisition Corp.
(Exact name of registrant as specified in its charter)
| Delaware | 001-40107 | 85-4391738 | ||
| (State or other jurisdiction | (Commission File Number) | (I.R.S. Employer | ||
| of incorporation) | Identification No.) |
| 865 S. Figueroa St., Suite 1800, Los Angeles, CA | 90017 | |
| (Address of principal executive offices) | (Zip Code) |
(213) 244-0000
(Registrant’s telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934:
| Title of each class | Trading Symbol(s) |
Name of each exchange on which registered | ||
| Units, each consisting of one share of Class A common stock and one-third of one redeemable warrant | TSPQ.U | New York Stock Exchange | ||
| Class A common stock, par value $0.0001 per share | TSPQ | New York Stock Exchange | ||
| Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 | TSPQ WS | New York Stock Exchange |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☑
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On March 15, 2021, Brian Lee was appointed to the board of directors (the “Board”) of TCW Special Purpose Acquisition Corp. (the “Company”). Effective March 15, 2021, Mr. Lee was also appointed to the Board’s (i) Audit Committee, (ii) Compensation Committee and (iii) Nominating and Corporate Governance Committee. The Board has determined that Mr. Lee is an independent director under applicable Securities and Exchange Commission and New York Stock Exchange rules.
In connection with the appointment of Mr. Lee, the Company entered into the following agreements:
| ● | A Letter Agreement, dated March 15, 2021 (the “Letter Agreement”), between the Company and Mr. Lee, pursuant to which Mr. Lee has agreed to: vote any shares of Class A common stock held by him in favor of the Company’s initial business combination; facilitate the liquidation and winding up of the Company if an initial business combination is not consummated within the time period required by its second amended and restated certificate of incorporation; and certain transfer restrictions with respect to the Company’s securities. |
| ● | An Indemnity Agreement, dated March 15, 2021 (the “Indemnity Agreement”), between the Company and Mr. Lee, providing Mr. Lee contractual indemnification in addition to the indemnification provided for in the Company’s second amended and restated certificate of incorporation. |
The foregoing descriptions of the Letter Agreement and the Indemnity Agreement do not purport to be complete and are qualified in their entireties by reference to the Letter Agreement and the Indemnity Agreement, copies of which are attached as Exhibits 10.1 and 10.2, respectively, and are incorporated herein by reference.
Other than the foregoing, Mr. Lee is not party to any arrangement or understanding with any person pursuant to which he was appointed as a director, nor is he party to any transactions required to be disclosed under Item 404(a) of Regulation S-K involving the Company.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits. The following exhibits are filed with this Form 8-K:
| Exhibit No. | Description of Exhibits | |
| 10.1 | Letter Agreement, dated March 15, 2021, between the Company and Mr. Lee. | |
| 10.2 | Indemnity Agreement, dated March 15, 2021, between the Company and Mr. Lee. |
1
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| TCW Special Purpose Acquisition Corp. | ||
| Date: March 16, 2021 | By: | /s/ Joseph R. Shaposhnik |
| Name: Joseph R. Shaposhnik | ||
| Title: Chief Executive Officer | ||
2